Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted
20 Dezember 2023 - 3:02PM
Update on the merger approval process for the combination of
Novozymes and Chr. Hansen: South Korean merger approval granted
December 20, 2023
Please see attachment.
Contact information
Investor RelationsDisa Tuominen+45 6038
5826dkditu@chr-hansen.com
Press RelationsSanne Seyer-Hansen+45 6038
6207dksash@chr-hansen.com
- 2023_South Korean merger approval granted
Chr Hansen (TG:51C)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Chr Hansen (TG:51C)
Historical Stock Chart
Von Nov 2023 bis Nov 2024